Evidence map›Paper›PMID 32557417›Full record

ArticleDiving and hyperbaric medicine2020

Experimental use of flow cytometry to detect bacteria viability after hyperbaric oxygen exposure: Work in progress report.

Miroslav Rozloznik, Alexandra Lochmanova, Dittmar Chmelar, Michal Hajek, Karin Korytkova, Monika Cisarikova

Open access · greenAbstract read
In one paragraph

Article in Diving and hyperbaric medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 3 countries.

Miroslav RozloznikDepartment of Biomedical Sciences, Faculty of Medicine, University of Ostrava, Czech Republic.
Alexandra LochmanovaDepartment of Biomedical Sciences, Faculty of Medicine, University of Ostrava, Czech Republic.
Dittmar ChmelarDepartment of Biomedical Sciences, Faculty of Medicine, University of Ostrava, Czech Republic.
Michal HajekDepartment of Biomedical Sciences, Faculty of Medicine, University of Ostrava, Czech Republic.
Karin KorytkovaDepartment of Biomedical Sciences, Faculty of Medicine, University of Ostrava, Czech Republic.
Monika CisarikovaDepartment of Biomedical Sciences, Faculty of Medicine, University of Ostrava, Czech Republic.
University of Ostrava · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHyperbaric oxygen treatment (HBOT), based on inhaling pure oxygen under elevated ambient pressure, is used as adjuvant intervention to promote healing in infected wounds. Despite extensive clinical evidence of beneficial effects of HBOT in soft tissue infections the mechanism of action remains to be elucidated. The aim of this study was to evaluate the use of flow cytometry as a novel method to assess the viability of pathogenic bacteria after hyperbaric oxygen (HBO) exposure.

methodsBacterial strains associated with soft tissues infections: Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus were exposed to oxygen at 2.8 atmospheres absolute (atm abs) (283.6 kPa) pressure for 45, 90, or 120 min, then stained with propidium iodide and thiazole orange and analysed by flow cytometry.

resultsEscherichia coli and Staphylococcus aureus showed no change in viability, nor morphology, the viability of Pseudomonas aeruginosa reduced in a dose-dependent manner and Klebsiella pneumoniae also showed dye uptake after HBO.

conclusionsThese initial results, indicate diverse sensitivity of bacteria to HBO, and suggest that flow cytometry can be used to monitor viability and morphological changes triggered by HBO exposure in bacteria.

Indexed as

Flow CytometryHyperbaric OxygenationMicrobial ViabilityBacteriaOxygenResearch ReportOxygenBacteriaFlow cytometryHyperbaric oxygen treatmentHyperoxiaWounds

Identifiers

PMID32557417
PMCPMC7481111
OpenAlexW3036623732

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.